QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)
QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)
QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)
QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)
NASDAQ:RDNT

RadNet (RDNT) Stock Price, News & Analysis

$46.84
+2.49 (+5.61%)
(As of 03/4/2024 ET)
Today's Range
$43.77
$48.50
50-Day Range
$33.57
$46.84
52-Week Range
$22.70
$48.50
Volume
1.49 million shs
Average Volume
425,236 shs
Market Capitalization
$3.21 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$40.50

RadNet MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
13.5% Downside
$40.50 Price Target
Short Interest
Healthy
3.78% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.52
Upright™ Environmental Score
News Sentiment
0.74mentions of RadNet in the last 14 days
Based on 24 Articles This Week
Insider Trading
Selling Shares
$354,227 Sold Last Quarter
Proj. Earnings Growth
21.05%
From $0.38 to $0.46 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.89 out of 5 stars

Medical Sector

203rd out of 948 stocks

Medical Laboratories Industry

9th out of 20 stocks


RDNT stock logo

About RadNet Stock (NASDAQ:RDNT)

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.

RDNT Stock Price History

RDNT Stock News Headlines

This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
StockNews.com Downgrades RadNet (NASDAQ:RDNT) to Sell
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
RadNet expands with Houston imaging center buy
Earnings Outlook For RadNet
Here's what to expect from RadNet's earnings report
RadNet (RDNT) Set to Announce Earnings on Friday
Radnet Inc.
RDNT Sep 2024 30.000 put
RDNT Jun 2024 30.000 put
See More Headlines
Receive RDNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for RadNet and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/01/2024
Today
3/04/2024
Next Earnings (Estimated)
5/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical laboratories
Sub-Industry
N/A
Current Symbol
NASDAQ:RDNT
Employees
10,288
Year Founded
1980

Price Target and Rating

Average Stock Price Target
$40.50
High Stock Price Target
$51.00
Low Stock Price Target
$30.00
Potential Upside/Downside
-25.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$3.04 million
Pretax Margin
2.40%

Debt

Sales & Book Value

Annual Sales
$1.62 billion
Cash Flow
$3.61 per share
Book Value
$11.79 per share

Miscellaneous

Free Float
65,442,000
Market Cap
$3.29 billion
Optionable
Optionable
Beta
1.66

Social Links

(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Dr. Howard G. Berger M.D. (Age 78)
    Chairman, President & CEO
    Comp: $5.56M
  • Mr. Mark D. Stolper (Age 53)
    Executive VP & CFO
    Comp: $1.13M
  • Mr. Mital Patel (Age 38)
    Executive VP of Financial Planning & Analysis and Chief Administrative Officer
    Comp: $1.15M
  • Mr. Norman R. HamesMr. Norman R. Hames (Age 68)
    President & COO of Western Operations
    Comp: $1.28M
  • Mr. Stephen M. Forthuber (Age 63)
    President & COO of Eastern Operations
    Comp: $1.3M
  • Ms. Christine Nayoma Gordon (Age 61)
    Senior VP of Operations - Northern California & Director
    Comp: $384.38k
  • Mr. Ranjan Jayanathan (Age 68)
    Executive VP, Chief Information Officer & GM of eRAD - Radiology Information Technology Division
  • Dr. Gregory Sorensen M.D. (Age 62)
    Executive VP, Chief Science Officer & Director
  • Ms. Laura Foster BSRT
    MPH, J.D., Senior Vice President of Compliance & Regulatory Affairs
  • Mr. David Jeffrey Katz (Age 59)
    Executive VP, Chief Legal Officer & Corporate Secretary














RDNT Stock Analysis - Frequently Asked Questions

Should I buy or sell RadNet stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for RadNet in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" RDNT shares.
View RDNT analyst ratings
or view top-rated stocks.

What is RadNet's stock price target for 2024?

2 brokerages have issued 1 year price objectives for RadNet's shares. Their RDNT share price targets range from $30.00 to $51.00. On average, they predict the company's share price to reach $40.50 in the next twelve months. This suggests that the stock has a possible downside of 13.5%.
View analysts price targets for RDNT
or view top-rated stocks among Wall Street analysts.

How have RDNT shares performed in 2024?

RadNet's stock was trading at $34.77 at the beginning of 2024. Since then, RDNT stock has increased by 34.7% and is now trading at $46.84.
View the best growth stocks for 2024 here
.

When is RadNet's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our RDNT earnings forecast
.

How were RadNet's earnings last quarter?

RadNet, Inc. (NASDAQ:RDNT) announced its earnings results on Friday, March, 1st. The medical research company reported $0.20 earnings per share for the quarter, topping the consensus estimate of $0.11 by $0.09. The medical research company earned $420.38 million during the quarter, compared to the consensus estimate of $410.11 million. RadNet had a net margin of 0.19% and a trailing twelve-month return on equity of 4.72%. RadNet's revenue for the quarter was up 9.5% compared to the same quarter last year. During the same period in the previous year, the company earned $0.11 EPS.

What guidance has RadNet issued on next quarter's earnings?

RadNet updated its FY 2024 earnings guidance on Thursday, February, 29th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.7 billion-$1.7 billion, compared to the consensus revenue estimate of $1.7 billion.

What is Howard G. Berger's approval rating as RadNet's CEO?

174 employees have rated RadNet Chief Executive Officer Howard G. Berger on Glassdoor.com. Howard G. Berger has an approval rating of 45% among the company's employees. This puts Howard G. Berger in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of RadNet own?

Based on aggregate information from My MarketBeat watchlists, some companies that other RadNet investors own include Advanced Micro Devices (AMD), AbbVie (ABBV), Inovio Pharmaceuticals (INO), NVIDIA (NVDA), OPKO Health (OPK), Boeing (BA), Rigel Pharmaceuticals (RIGL), UnitedHealth Group (UNH), Pfizer (PFE) and AT&T (T).

Who are RadNet's major shareholders?

RadNet's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (6.17%), Dimensional Fund Advisors LP (2.53%), Edmond DE Rothschild Holding S.A. (2.24%), Principal Financial Group Inc. (1.87%), Point72 Asset Management L.P. (1.29%) and Global Alpha Capital Management Ltd. (1.27%). Insiders that own company stock include Christine Nayoma Gordon, David L Swartz, John V Crues, Lawrence L Levitt, Lawrence L Levitt, Michael N Murdock, Norman R Hames and Ruth Louisa Villigerwilson.
View institutional ownership trends
.

How do I buy shares of RadNet?

Shares of RDNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:RDNT) was last updated on 3/4/2024 by MarketBeat.com Staff